[January 16, 2018]

The Global Market for Cancer Stem Cells Will Grow from $745 Million in 2017 to $1.9 Billion by 2022 with a Compound Annual Growth Rate of 21.2% for the Period of 2017-2022 - Research and Markets

The "Cancer Stem Cells: Technologies and Global Markets" report has been added to Research and Markets' offering.

The Global Market for Cancer Stem Cells Will Grow from $745 Million in 2017 to $1.9 Billion by 2022 with a Compound Annual Growth Rate of 21.2% for the Period of 2017-2022

Report Includes:

• 27 data tables and 25 additional tables
• An overview of the global market for cancer stem cells and related technologies
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
• Segmentation of the market by type and by region
• Discussion of market dynamics, including drivers, restraints, and opportunities
• Insight into the competitive landscape, including strategies, acquisitions, agreements, and new product launches
• Profiles of suppliers of cancer stem cells and analyses based on market share, cancer type, and region

Report Scope:

This research report presents an in-depth analysis of the global cancer stem cells market by cancer type and geographic markets. The report includes key inhibitors that affect various factors that help in growth of cancer stem cells. The report discusses the role of supply chain members from manufacturers to researchers. The repor has an in-depth analysis of key companies operating in the global cancer stem cells market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe, and China.

The cancer stem cells market is mainly segmented into two major components: cancer type and geography. Based on cancer type, the market is segmented into lung cancer, breast cancer, colorectal cancer, leukemia, melanoma, prostate cancer, brain cancer, bone cancer, and other types of cancer. The market is segmented by geography into the North America, Europe, Asia-Pacific, and ROW.MBA in marketing.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Chapter 4 Market Breakdown by Technology Type and Region

Chapter 5 Market Breakdown by Application

Chapter 6 Industry Structure

Chapter 7 Patent Review/ New Developments

Chapter 8 Analysis of Market Opportunities

Chapter 9 Company Profiles

Chapter 10 Appendix: Abbreviations

Companies Mentioned

• Abbott Laboratories
• Abbvie Inc.
• Amgen Inc.
• Astrazeneca Plc
• Bayer Ag
• Boehringer Ingelheim International Gmbh
• Bristol-Myers Squibb
• Cipla Usa Inc.
• Clovis Oncology
• Daiichi-Sankyo Co. Ltd
• Dr. Reddy's Laboratories Ltd.
• Eisai Inc.
• Eli Lilly And Co.
• F. Hoffmann-La Roche Ag
• Gilead Sciences Inc.
• Glaxosmithkline Plc
• Glenmark Pharmaceuticals Limited
• Incyte Corp.
• Janssen Global Services Llc
• Kowa Pharmaceuticals America Inc.
• Lupin Pharmaceuticals Inc.
• Merck & Co. Inc.
• Merck Kgaa
• Novartis Holding Ag
• Pfizer Inc.
• Sanofi Genzyme Corp.
• Servier
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceuticals Co.
• Teva Pharmaceutical Industries Ltd.
• Valeant Pharmaceuticals International Inc.
• Viiv Healthcare
• Vivus Inc.
• Zydus Cadila

For more information about this report visit https://www.researchandmarkets.com/research/2fs25d/cancer_stem?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180116005879/en/

[ Back To TMCnet.com's Homepage ]